Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2011 Mar;4(3):303-6.
doi: 10.1158/1940-6207.CAPR-11-0053.

Challenges related to developing serum-based biomarkers for early ovarian cancer detection

Phuong L Mai  1 , Nicolas Wentzensen, Mark H Greene
Affiliations
Comment

Challenges related to developing serum-based biomarkers for early ovarian cancer detection

Phuong L Mai et al. Cancer Prev Res (Phila). 2011 Mar.

Abstract

In this issue of the journal, Cramer and colleagues and Zhu and colleagues report carefully designed phase 3 assessments of candidate ovarian cancer screening biomarkers. The main conclusion is that CA-125 remains the "best of a bad lot"; the new candidates have fallen short of expectations. We review factors impeding the development of an effective ovarian cancer screening strategy, highlight the requirements related to validating proposed screening biomarkers, and emphasize the risks from premature clinical applications of unvalidated tests, all underscoring the need for new research strategies.

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010 Sep-Oct;60(5):277–300. - PubMed
    1. Bast RC, Jr., Feeney M, Lazarus H, Nadler LM, Colvin RB, Knapp RC. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981 Nov;68(5):1331–7. - PMC - PubMed
    1. Bouanene H, Miled A. Conflicting views on the molecular structure of the cancer antigen CA125/MUC16. Dis Markers. 2010;28(6):385–94. - PMC - PubMed
    1. Karam AK, Karlan BY. Ovarian cancer: the duplicity of CA125 measurement. Nat Rev Clin Oncol. 2010 Jun;7(6):335–9. - PubMed
    1. Einhorn N, Sjovall K, Knapp RC, Hall P, Scully RE, Bast RC, Jr., et al. Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol. 1992 Jul;80(1):14–8. - PubMed

Publication types

Substances